Abstract
Objective
The aim of this study was to investigate the roles of miR-130b-3p and ICAM-1 in gestational diabetes mellitus (GDM) and their potential association.
Methods
Human placenta mesenchymal stem cells (PlaMSCs) were isolated from GDM patients, and the effects of the PlaMSCs from GDM patients (GDM-MSCs) and the exosomes secreted by GDM-MSCs on human umbilical vein endothelial cell (HUVEC) proliferation, migration, and angiogenesis were detected. Next, GDM-MSCs were transfected with miR-130b-3p antagomir to modify miR-130b-3p expression in GDM-MSCs-derived exosomes, and the exosomes with modified miR-130b-3p expression were cultured with HUVECs to evaluate exosomal miR-130b-3p on HUVEC function. Furthermore, a target gene of miR-130b-3p was predicted and assessed. The miR-130b-3p-modified exosomes were cultured with HUVECs transfected with ICAM-1 shRNA to determine the effect of miR-130b-3p-ICAM-1 crosstalk on HUVEC function. Additionally, a GDM mouse model was conducted to further study the effect of miR-130b-3p in GDM in vivo.
Results
GDM-MSCs inhibited HUVEC proliferation and angiogenesis. The elevated expression of miR-130b-3p was found in GDM-MSCs-derived exosomes. GDM-MSCs-derived exosomes repressed the proliferation and angiogenesis of HUVECs and miR-130b-3p inhibition could restrain the inhibition of the exosomes on HUVEC function. Mechanistically, miR-130b-3p downregulated ICAM-1 expression in a targeted manner, and thereby enhanced HUVEC proliferation, migration, and angiogenesis and increased the expression of angiogenesis-related factors. Moreover, miR-130b-3p inhibition promoted placental angiogenesis in GDM mice and upregulated ICAM-1 expression.
Conclusion
Conclusively, GDM-MSCs-derived exosomes shuttling miR-130b-3p repressed proliferation, migration, and angiogenesis of HUVECs by regulating ICAM-1 expression.
Similar content being viewed by others
Availability of data and materials
The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.
References
Chiefari E et al (2017) Gestational diabetes mellitus: an updated overview. J Endocrinol Invest 40(9):899–909
Casagrande SS et al (2018) Prevalence of gestational diabetes and subsequent Type 2 diabetes among U.S. women. Diabetes Res Clin Pract 141:200–208
Johns EC et al (2018) Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab 29(11):743–754
McElwain CJ et al (2020) Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: windows into future cardiometabolic health? Front Endocrinol (Lausanne) 11:655
Schiano C et al (2020) Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro 62:104694
Valencia-Quintana R et al (2022) miRNAs: a potentially valuable tool in pesticide toxicology assessment-current experimental and epidemiological data review. Chemosphere 295:133792
Liu C et al (2021) Mitochondrial dysfunction contributes to aging-related atrial fibrillation. Oxid Med Cell Longev 2021:5530293
Zheng H et al (2022) MicroRNA-195-5p facilitates endothelial dysfunction by inhibiting vascular endothelial growth factor A in gestational diabetes mellitus. Reprod Biol 22(1):100605
Hromadnikova I et al (2020) Diabetes mellitus and cardiovascular risk assessment in mothers with a history of gestational diabetes mellitus based on postpartal expression profile of micrornas associated with diabetes mellitus and cardiovascular and cerebrovascular diseases. Int J Mol Sci 21(7):2437
Tryggestad JB et al (2016) Influence of gestational diabetes mellitus on human umbilical vein endothelial cell miRNA. Clin Sci (Lond) 130(21):1955–1967
He C et al (2018) Exosome theranostics: Biology and translational medicine. Theranostics 8(1):237–255
Yu B et al (2014) Exosomes derived from mesenchymal stem cells. Int J Mol Sci 15(3):4142–4157
Komaki M et al (2017) Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis. Stem Cell Res Ther 8(1):219
Huang Y et al (2021) Exosomal circular RNA circ_0074673 regulates the proliferation, migration, and angiogenesis of human umbilical vein endothelial cells via the microRNA-1200/MEOX2 axis. Bioengineered 12(1):6782–6792
Yang X et al (2022) MicroRNAs and exosomal micrornas may be possible targets to investigate in gestational diabetes mellitus. Diabetes Metab Syndr Obes 15:321–330
Yan W et al (2021) Exosomal miR-130b-3p promotes progression and tubular formation through targeting PTEN in oral squamous cell carcinoma. Front Cell Dev Biol 9:616306
Guo P et al (2016) ICAM-1-Targeted, Lcn2 siRNA-encapsulating liposomes are potent anti-angiogenic agents for triple negative breast cancer. Theranostics 6(1):1–13
Diaz-Perez FI et al (2016) Post-transcriptional down regulation of ICAM-1 in feto-placental endothelium in GDM. Cell Adh Migr 10(1–2):18–27
Tooi M et al (2016) Placenta mesenchymal stem cell derived exosomes confer plasticity on fibroblasts. J Cell Biochem 117(7):1658–1670
Fan X et al (2014) Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest 124(11):4941–4952
Neres R et al (2008) Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women. PLoS ONE 3(2):e1608
Wang Z et al (2012) Cadmium-induced teratogenicity: association with ROS-mediated endoplasmic reticulum stress in placenta. Toxicol Appl Pharmacol 259(2):236–247
Xiong YW et al (2021) Environmental exposure to cadmium impairs fetal growth and placental angiogenesis via GCN-2-mediated mitochondrial stress. J Hazard Mater 401:123438
Xiong YW et al (2020) Maternal cadmium exposure during late pregnancy causes fetal growth restriction via inhibiting placental progesterone synthesis. Ecotoxicol Environ Saf 187:109879
Getahun D et al. (2010) Gestational diabetes: risk of recurrence in subsequent pregnancies. Am J Obstet Gynecol 203(5): 467 e1–e6
Saez T et al (2018) Is there a role for exosomes in foetoplacental endothelial dysfunction in gestational diabetes mellitus? Placenta 61:48–54
Chen Y et al (2021) Non-invasive detection of fetal vascular endothelial function in gestational diabetes mellitus. Front Endocrinol (Lausanne) 12:763683
Chen L et al (2020) Chorionic and amniotic placental membrane-derived stem cells, from gestational diabetic women, have distinct insulin secreting cell differentiation capacities. J Tissue Eng Regen Med 14(2):243–256
Ma H et al (2021) Conditioned medium from primary cytotrophoblasts, primary placenta-derived mesenchymal stem cells, or sub-cultured placental tissue promoted HUVEC angiogenesis in vitro. Stem Cell Res Ther 12(1):141
Pan J et al (2019) MSCs inhibits the angiogenesis of HUVECs through the miR-211/Prox1 pathway. J Biochem 166(1):107–113
Silva L et al (2017) Insulin/adenosine axis linked signalling. Mol Aspects Med 55:45–61
Sultan SA et al (2015) The role of maternal gestational diabetes in inducing fetal endothelial dysfunction. J Cell Physiol 230(11):2695–2705
Van Linthout S et al (2017) Placenta-derived adherent stromal cells improve diabetes mellitus-associated left ventricular diastolic performance. Stem Cells Transl Med 6(12):2135–2145
Jiang S et al (2017) Role of microRNA-130b in placental PGC-1alpha/TFAM mitochondrial biogenesis pathway. Biochem Biophys Res Commun 487(3):607–612
Chen J et al (2021) Endocan: a key player of cardiovascular disease. Front Cardiovasc Med 8:798699
Turan M et al (2022) Immunoreactivity of ICAM-1, MMP-2, and Nesfatin-1 in lens epithelial cells of patients with diabetes mellitus with or without diabetic retinopathy. Eur J Ophthalmol 32(1):255–262
Zheng Y et al (2021) Crocetin suppresses gestational diabetes in streptozotocin-induced diabetes mellitus rats via suppression of inflammatory reaction. J Food Biochem 45(9):e13857
Kurt M et al (2010) Expression of intercellular adhesion molecule-1 in umbilical and placental vascular tissue of gestational diabetic and normal pregnancies. Arch Gynecol Obstet 281(1):71–76
Tang G et al (2021) Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Acta Pharm Sin B 11(9):2749–2767
Szilagyi B et al (2021) Platelet microparticles enriched in miR-223 reduce ICAM-1-dependent vascular inflammation in septic conditions. Front Physiol 12:658524
Acknowledgements
Not applicable.
Funding
Thanks for the grant from the General Project of Natural Science Foundation of Hunan Province (Grant No. 2021JJ31024).
Author information
Authors and Affiliations
Contributions
GZ and WN contributed equally to the manuscript, GZ, WN, and LXL had full access to all of the data in the study and takes responsibility for the integrity of the data, the accuracy of the data analysis, GZ, WN, and LXL wrote the manuscript draft. GZ, WN, and LXL performed research. GZ and WN contributed substantially to the study design and the writing of the manuscript. GZ, WN, and LXL contributed to the manuscript preparation and statistical analysis. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The author declares no competing financial interests.
Ethics approval
This work was authorized by The Third Xiangya Hospital of Central South University, and written informed consent was collected from all participants.
Consent to participate
Informed consent to participate in the study was obtained from participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article belongs to the topical collection Pregnancy and Diabetes, managed by Antonio Secchi and Marina Scavini.
Supplementary Information
Below is the link to the electronic supplementary material.
592_2022_1910_MOESM1_ESM.tif
Supplementary file1 The expression of exosome markers CD9, CD63, and a endoplasmic reticulum maker Calnexin in the isolated exosomes was detected by western blot. Notes: A, CD9 expression was measured by western blot. B, CD63 expression was tested by western blot. C, Calnexin expression was evaluated by western blot. In addition to Marker, the bands from left to right in the figures sequentially represents the CON-MSCs, GDM -MSCs, CON-PdEs, GDM-PdEs, and CON-PdEs and GDM-PdEs isolated after GW4869 addition. CON-PdEs, exosomes derived by CON-MSCs; GDM-PdEs, exosomes derived by GDM-MSCs; CON-MSCs, PlaMSC from healthy volunteers; GDM-MSCs, PlaMSCs from GDM patients; GDM, gestational diabetes mellitus; PlaMSCs, mesenchymal stem cells from placenta (TIF 54838 kb)
Rights and permissions
About this article
Cite this article
Gao, Z., Wang, N. & Liu, X. Human placenta mesenchymal stem cell-derived exosome shuttling microRNA-130b-3p from gestational diabetes mellitus patients targets ICAM-1 and perturbs human umbilical vein endothelial cell angiogenesis. Acta Diabetol 59, 1091–1107 (2022). https://doi.org/10.1007/s00592-022-01910-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-022-01910-2